Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
8.90
-0.07 (-0.78%)
At close: Jun 04, 2025, 3:59 PM
8.83
-0.79%
After-hours: Jun 04, 2025, 07:20 PM EDT

Company Description

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases.

The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome.

It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease.

The company is based in Ashburn, Virginia.

Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. logo
Country United States
IPO Date Aug 1, 2016
Industry Biotechnology
Sector Healthcare
Employees 3
CEO Dr. Michael Myers Ph.D.

Contact Details

Address:
42127 Pleasant Forest Court
Ashburn, Virginia
United States
Website https://quoinpharma.com

Stock Details

Ticker Symbol QNRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001671502
CUSIP Number 74907L102
ISIN Number US74907L3006
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Dr. Michael Myers Ph.D. Co-Founder, Chief Executive Officer & Chairman
Denise Carter Co-Founder, Chief Operating Officer & Director
Gordon Bruce Dunn J.D. Chief Financial Officer

Latest SEC Filings

Date Type Title
Jun 03, 2025 4 Filing
Jun 02, 2025 4 Filing
Jun 02, 2025 4 Filing
Jun 02, 2025 4 Filing
Jun 02, 2025 4 Filing
Jun 02, 2025 4 Filing
Jun 02, 2025 4 Filing
May 23, 2025 8-K Current Report
May 21, 2025 8-K Current Report
May 15, 2025 SCHEDULE 13G/A [Amend] Filing